Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

477 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression.
Peretz Y, Ndongala ML, Boulet S, Boulassel MR, Rouleau D, Côté P, Longpré D, Routy JP, Falutz J, Tremblay C, Tsoukas CM, Sékaly RP, Bernard NF. Peretz Y, et al. Among authors: routy jp. Clin Immunol. 2007 Jul;124(1):57-68. doi: 10.1016/j.clim.2007.04.004. Epub 2007 May 22. Clin Immunol. 2007. PMID: 17521962
Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.
Salomon H, Wainberg MA, Brenner B, Quan Y, Rouleau D, Coté P, LeBlanc R, Lefebvre E, Spira B, Tsoukas C, Sekaly RP, Conway B, Mayers D, Routy JP. Salomon H, et al. Among authors: routy jp. AIDS. 2000 Jan 28;14(2):F17-23. doi: 10.1097/00002030-200001280-00003. AIDS. 2000. PMID: 10708278
Comparison of clinical features of acute HIV-1 infection in patients infected sexually or through injection drug use. The Investigators of the Québec Primary HIV Infection Study.
Routy JP, Vanhems P, Rouleau D, Tsoukas C, Lefèbvre E, Côté P, LeBlanc R, Conway B, Alary M, Bruneau J, Sekaly RP. Routy JP, et al. J Acquir Immune Defic Syndr. 2000 Aug 15;24(5):425-32. doi: 10.1097/00126334-200008150-00004. J Acquir Immune Defic Syndr. 2000. PMID: 11035609
Improvement of HIV-specific immunity in HIV-infected twins treated with highly active antiretroviral therapy, interleukin 2, and syngeneic adoptively transferred cells.
Tsoukas CM, Turner HM, Hatzakis GE, Blake GP, Goodhew JE, Kilby DL, Kovacs CM, Luetkehoelter JR, Routy JP, Walmsley SL, Bernard NF. Tsoukas CM, et al. Among authors: routy jp. AIDS Res Hum Retroviruses. 2001 Jul 1;17(10):887-900. doi: 10.1089/088922201750290014. AIDS Res Hum Retroviruses. 2001. PMID: 11461675 Clinical Trial.
Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection.
Alter G, Hatzakis G, Tsoukas CM, Pelley K, Rouleau D, LeBlanc R, Baril JG, Dion H, Lefebvre E, Thomas R, Côté P, Lapointe N, Routy JP, Sékaly RP, Conway B, Bernard NF. Alter G, et al. Among authors: routy jp. J Immunol. 2003 Jul 1;171(1):477-88. doi: 10.4049/jimmunol.171.1.477. J Immunol. 2003. PMID: 12817033
477 results